Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses.
作者信息
Zhou J, Chau Y-L A, Yoo J W, Lee S, Ng K, Dee E C, Liu T, Wai A K C, Zhang Q, Tse G
机构信息
Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Faculty of Pharmaceutical Sciences, The University of British Columbia, British Columbia, Canada.
出版信息
Clin Oncol (R Coll Radiol). 2022 Jul;34(7):e316-e317. doi: 10.1016/j.clon.2022.03.006. Epub 2022 Mar 20.
PMID:35321832
Abstract
摘要
Zotero 插件